Health Tracking
9 articles on Health Tracking, written by Shotlee and medically reviewed for clinical accuracy.
GLP-1 Weight Loss & The Changing Landscape: Navigating Semaglutide & Beyond
The GLP-1 weight loss market is experiencing significant shifts with new leadership and competitive pressures. This article dives into the latest developments surrounding semaglutide, Ozempic, and Wegovy, and explores the broader impact on health and wellness.
4 min read
GLP-1s & Metabolic Health: New Research Links Peptide Therapy to Reduced Arthritis Risk
New research shows that GLP-1 receptor agonists, often used for diabetes and weight loss, may reduce the risk of certain types of arthritis. This blog post explores the potential benefits of this peptide therapy, offering actionable insights for improved health and wellness.
4 min read
US Obesity Rates Decline: Are GLP-1 Drugs Like Ozempic & Wegovy the Answer?
New data reveals a drop in US obesity rates, and GLP-1 drugs like Ozempic and Wegovy are likely playing a significant role. This post explores the impact of these medications and what it means for your health.
4 min read
Direct-to-Consumer Pricing: A New Era for GLP-1 Medications and Wellness?
The pharmaceutical landscape is shifting. Direct-to-consumer pricing for medications like GLP-1s is gaining traction. This could reshape how we access and afford treatments for weight loss and metabolic health. Learn how this might affect your wellness.
3 min read
GLP-1 Weight Loss & Body Image: Navigating the Complexities of Health & Criticism
This post dives into the complexities of GLP-1 medications, body image, and navigating criticism in your health journey, offering actionable tips for wellness.
3 min read
GLP-1 Medications & Weight Loss: Jonathan Van Ness's Journey & Your Health
Jonathan Van Ness recently shared his experience with GLP-1 medications for weight loss. This post delves into the science behind these medications, their impact on metabolic health, and how to make informed choices about your well-being.
4 min read
Semaglutide Setback: What the Canadian Regulatory Delay Means for Weight Loss & Metabolic Health
Dr. Reddy's faced a setback in Canada for its Semaglutide Injection submission. This news highlights the complexities of bringing vital medications like GLP-1 receptor agonists to market. Here’s what you need to know about this development and its impact on weight loss and health.
4 min read
GLP-1 Weight Loss Drugs and the Decline in Obesity: What You Need to Know
New data reveals a drop in obesity rates alongside increased use of GLP-1 weight-loss drugs. This blog explores the connection, offers actionable insights, and discusses the implications for your health and wellness journey.
4 min read
The Dangers of Black Market Weight Loss Injections: Understanding GLP-1 and Staying Safe
This post explores the risks associated with black market weight loss injections, emphasizing the importance of safety and informed healthcare choices. Understanding the potential dangers of unregulated treatments, such as semaglutide, is crucial for your well-being.
4 min read